Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125

1.

Insights into the polymorphism in HLA-DRA and its evolutionary relationship with HLA haplotypes.

Matern BM, Olieslagers TI, Voorter CEM, Groeneweg M, Tilanus MGJ.

HLA. 2020 Feb;95(2):117-127. doi: 10.1111/tan.13730. Epub 2019 Nov 10.

PMID:
31617688
2.

Antibodies against ARHGDIB are associated with long-term kidney graft loss.

Kamburova EG, Gruijters ML, Kardol-Hoefnagel T, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Melchers RCA, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Bemelman FJ, Otten HG.

Am J Transplant. 2019 Dec;19(12):3335-3344. doi: 10.1111/ajt.15493. Epub 2019 Jul 3.

3.

Allocation to highly sensitized patients based on acceptable mismatches results in low rejection rates comparable to nonsensitized patients.

Heidt S, Haasnoot GW, Witvliet MD, van der Linden-van Oevelen MJH, Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Otten HG, Roelen DL, Claas FHJ.

Am J Transplant. 2019 Oct;19(10):2926-2933. doi: 10.1111/ajt.15486. Epub 2019 Jul 1.

4.

Development and Validation of a Multiplex Non-HLA Antibody Assay for the Screening of Kidney Transplant Recipients.

Kamburova EG, Kardol-Hoefnagel T, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Meeldijk J, Bovenschen N, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Bemelman FJ, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

Front Immunol. 2018 Dec 19;9:3002. doi: 10.3389/fimmu.2018.03002. eCollection 2018.

5.

Effect of initial immunosuppression on long-term kidney transplant outcome in immunological low-risk patients.

Michielsen LA, van Zuilen AD, Verhaar MC, Wisse BW, Kamburova EG, Joosten I, Allebes WA, van der Meer A, Baas MC, Spierings E, Hack CE, van Reekum FE, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JF, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG, Hilbrands LB.

Nephrol Dial Transplant. 2019 Aug 1;34(8):1417-1422. doi: 10.1093/ndt/gfy377.

PMID:
30561730
6.

A comprehensive overview of FCGR3A gene variability by full-length gene sequencing including the identification of V158F polymorphism.

Mahaweni NM, Olieslagers TI, Rivas IO, Molenbroeck SJJ, Groeneweg M, Bos GMJ, Tilanus MGJ, Voorter CEM, Wieten L.

Sci Rep. 2018 Oct 29;8(1):15983. doi: 10.1038/s41598-018-34258-1.

7.

A paired kidney analysis on the impact of pre-transplant anti-HLA antibodies on graft survival.

Michielsen LA, Wisse BW, Kamburova EG, Verhaar MC, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JF, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG, van Zuilen AD.

Nephrol Dial Transplant. 2019 Jun 1;34(6):1056-1063. doi: 10.1093/ndt/gfy316.

PMID:
30365008
8.

Full-length extension of HLA allele sequences by HLA allele-specific hemizygous Sanger sequencing (SSBT).

Voorter CEM, Matern B, Tran TH, Fink A, Vidan-Jeras B, Montanic S, Fischer G, Fae I, de Santis D, Whidborne R, Andreani M, Testi M, Groeneweg M, Tilanus MGJ.

Hum Immunol. 2018 Nov;79(11):763-772. doi: 10.1016/j.humimm.2018.08.004. Epub 2018 Aug 11.

PMID:
30107213
9.

Toward a Sensible Single-antigen Bead Cutoff Based on Kidney Graft Survival.

Wisse BW, Kamburova EG, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Stephan Sanders J, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma AJ, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

Transplantation. 2019 Apr;103(4):789-797. doi: 10.1097/TP.0000000000002357.

10.

Pretransplant C3d-Fixing Donor-Specific Anti-HLA Antibodies Are Not Associated with Increased Risk for Kidney Graft Failure.

Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma AJ, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

J Am Soc Nephrol. 2018 Sep;29(9):2279-2285. doi: 10.1681/ASN.2018020205. Epub 2018 Jul 26.

11.

PIRCHE-II Is Related to Graft Failure after Kidney Transplantation.

Geneugelijk K, Niemann M, Drylewicz J, van Zuilen AD, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Hack CE, van Reekum FE, Verhaar MC, Kamburova EG, Bots ML, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MGJ, Vanderlocht J, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MHL, van Ittersum FJ, Nurmohamed A, Lardy JNM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG, Spierings E.

Front Immunol. 2018 Mar 5;9:321. doi: 10.3389/fimmu.2018.00321. eCollection 2018.

12.

Differential effects of donor-specific HLA antibodies in living versus deceased donor transplant.

Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JSF, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

Am J Transplant. 2018 Sep;18(9):2274-2284. doi: 10.1111/ajt.14709. Epub 2018 Apr 16.

13.

A new HLA-C*05 allele, HLA-C*05:156, characterized by full-length hemizygous sequencing.

Montanic S, Voorter CEM, Tilanus MGJ, Vidan-Jeras B.

HLA. 2018 Mar;91(3):212-213. doi: 10.1111/tan.13215.

PMID:
29356391
14.

Saddlebags: A software interface for submitting full-length HLA allele sequences to the EMBL-ENA nucleotide database.

Matern BM, Groeneweg M, Voorter CEM, Tilanus MGJ.

HLA. 2018 Jan;91(1):29-35. doi: 10.1111/tan.13179.

PMID:
29160623
15.

Description of four new HLA alleles in the Finnish population: A*03:283N, A*68:167, C*03:327, C*03:361.

Polvi A, Peräsaari J, Linjama T, Saarinen T, Koskela S, Voorter CEM, Jaatinen T.

HLA. 2018 Jan;91(1):61-62. doi: 10.1111/tan.13158. Epub 2017 Oct 24.

PMID:
29030950
16.

Polymorphism at residue 156 of the new HLA-A*02:683 allele suggests immunological relevance.

Duygu B, Matern BM, Groeneweg M, Voorter CEM, Tilanus MGJ.

HLA. 2017 Aug;90(2):107-109. doi: 10.1111/tan.13059. Epub 2017 May 28.

PMID:
28556601
17.

New insights in HLA-E polymorphism by refined analysis of the full-length gene.

Olieslagers TI, Voorter CE, Groeneweg M, Xu Y, Wieten L, Tilanus MG.

HLA. 2017 Mar;89(3):143-149. doi: 10.1111/tan.12965. Epub 2017 Jan 27.

PMID:
28127896
18.

Human leukocyte antigen typing using buccal swabs as accurate and non-invasive substitute for venipuncture in children at risk for celiac disease.

Adriaanse MP, Vreugdenhil AC, Vastmans V, Groeneveld L, Molenbroeck S, Schott DA, Voorter CE, Tilanus MG.

J Gastroenterol Hepatol. 2016 Oct;31(10):1711-1716. doi: 10.1111/jgh.13331.

PMID:
26945703
19.

The increase of the global donor inventory is of limited benefit to patients of non-Northwestern European descent.

van Walraven SM, Brand A, Bakker JN, Heemskerk MB, Nillesen S, Bierings MB, Bungener LB, Hepkema BG, Lankester A, van der Meer A, Sintnicolaas K, Somers JA, Spierings E, Tilanus MG, Voorter CE, Cornelissen JJ, Oudshoorn M.

Haematologica. 2017 Jan;102(1):176-183. doi: 10.3324/haematol.2016.145730. Epub 2016 Aug 25.

20.

How can we reduce costs of solid-phase multiplex-bead assays used to determine anti-HLA antibodies?

Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar M, Bots ML, Drop AC, Plaisier L, Seelen MA, Sanders JS, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MG, Vanderlocht J, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MH, van Ittersum FJ, Nurmohamed A, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJ, Bemelman FJ, Hoitsma A, van der Boog PJ, de Fijter JW, Betjes MG, Heidt S, Roelen DL, Claas FH, Otten HG.

HLA. 2016 Sep;88(3):110-9. doi: 10.1111/tan.12860. Epub 2016 Aug 18.

PMID:
27534609
21.

The role of gene polymorphism in HLA class I splicing.

Voorter CE, Gerritsen KE, Groeneweg M, Wieten L, Tilanus MG.

Int J Immunogenet. 2016 Apr;43(2):65-78. doi: 10.1111/iji.12256. Epub 2016 Feb 27. Review.

PMID:
26920492
22.

Uncommon HLA alleles identified by hemizygous ultra-high Sanger sequencing: haplotype associations and reconsideration of their assignment in the Common and Well-Documented catalogue.

Voorter CE, Groeneweg M, Groeneveld L, Tilanus MG.

Hum Immunol. 2016 Feb;77(2):184-90. doi: 10.1016/j.humimm.2015.11.016. Epub 2015 Nov 30.

PMID:
26610902
23.

Full-length HLA-DRB1 coding sequences generated by a hemizygous RNA-SBT approach.

Gerritsen KE, Groeneweg M, Meertens CM, Voorter CE, Tilanus MG.

Tissue Antigens. 2015 Nov;86(5):333-42. doi: 10.1111/tan.12654. Epub 2015 Sep 23.

PMID:
26396036
24.

HLA-E regulates NKG2C+ natural killer cell function through presentation of a restricted peptide repertoire.

Lauterbach N, Wieten L, Popeijus HE, Voorter CE, Tilanus MG.

Hum Immunol. 2015 Aug;76(8):578-86. doi: 10.1016/j.humimm.2015.09.003. Epub 2015 Sep 14.

PMID:
26382247
25.

Features of a new full length HLA allele: A*02:455.

Crijns VB, Groeneweg M, Schouten HC, Voorter CE, Tilanus MG.

Tissue Antigens. 2015 Jul;86(1):53-5. doi: 10.1111/tan.12579. Epub 2015 May 11.

PMID:
25959797
26.

Peptide-induced HLA-E expression in human PBMCs is dependent on peptide sequence and the HLA-E genotype.

Lauterbach N, Wieten L, Popeijus HE, Vanderlocht J, van Zon PM, Voorter CE, Tilanus MG.

Tissue Antigens. 2015 Apr;85(4):242-51. doi: 10.1111/tan.12525. Epub 2015 Mar 4.

PMID:
25735891
27.

RNA and protein expression of HLA-A(∗)23:19Q.

Gerritsen KE, Voorter CE, Joannes MO, Senden-Gijsbers BL, Agis F, Wieten L, Tilanus MG.

Hum Immunol. 2015 Apr;76(4):286-91. doi: 10.1016/j.humimm.2015.02.001. Epub 2015 Feb 9.

PMID:
25676117
28.

The full length genomic sequence of a novel HLA-C*03 allele: HLA-C*03:219.

Crijns VB, Palusci F, Schouten HC, Voorter CE, Tilanus MG.

Tissue Antigens. 2015 Jan;85(1):75-6. doi: 10.1111/tan.12485. Epub 2014 Dec 16.

PMID:
25515183
29.

Clinical and immunological significance of HLA-E in stem cell transplantation and cancer.

Wieten L, Mahaweni NM, Voorter CE, Bos GM, Tilanus MG.

Tissue Antigens. 2014 Dec;84(6):523-35. doi: 10.1111/tan.12478. Review.

PMID:
25413103
30.

The PROCARE consortium: toward an improved allocation strategy for kidney allografts.

Otten HG, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas M, Spierings E, Hack CE, van Reekum F, van Zuilen AD, Verhaar MC, Bots ML, Seelen MA, Sanders JS, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MG, Vanderlocht J, Voorter CE, Wieten L, van Duijnhoven E, Gelens M, Christiaans M, van Ittersum F, Nurmohamed A, Lardy NM, Swelsen WT, van Donselaar-van der Pant KA, van der Weerd NC, Ten Berge IJ, Bemelman FJ, Hoitsma AJ, de Fijter JW, Betjes MG, Roelen DL, Claas FH.

Transpl Immunol. 2014 Oct;31(4):184-90. doi: 10.1016/j.trim.2014.09.008. Epub 2014 Oct 1.

PMID:
25258025
31.

An improved and validated RNA HLA class I SBT approach for obtaining full length coding sequences.

Gerritsen KE, Olieslagers TI, Groeneweg M, Voorter CE, Tilanus MG.

Tissue Antigens. 2014 Nov;84(5):450-8. doi: 10.1111/tan.12436. Epub 2014 Sep 23.

PMID:
25251784
32.

The Maastricht Transplant Center: clinical setting and epitope searches in HLA class II molecules: does the structural localization of a polymorphic site contribute to its immunogenicity?

Schellekens J, Vanderlocht J, Groeneweg M, Voorter CE, Wieten L, Gelens MA, van Duijnhoven EM, van Heurn LW, Christiaans MH, Tilanus MG.

Transpl Immunol. 2014 Oct;31(4):213-8. doi: 10.1016/j.trim.2014.09.002. Epub 2014 Sep 21. Review.

PMID:
25240735
33.

Sequence-based typing of HLA: an improved group-specific full-length gene sequencing approach.

Voorter CE, Palusci F, Tilanus MG.

Methods Mol Biol. 2014;1109:101-14. doi: 10.1007/978-1-4614-9437-9_7.

PMID:
24473781
34.

Allorecognition of HLA-DP by CD4+ T cells is affected by polymorphism in its alpha chain.

Lauterbach N, Crivello P, Wieten L, Zito L, Groeneweg M, Voorter CE, Fleischhauer K, Tilanus MG.

Mol Immunol. 2014 May;59(1):19-29. doi: 10.1016/j.molimm.2013.12.006. Epub 2014 Jan 22.

PMID:
24462895
35.

Allele and haplotype frequencies of HLA-DPA1 and -DPB1 in the population of Guadeloupe.

Voorter CE, Groeneweg M, Joannis MO, Meertens C, Agis F, Tilanus MG.

Tissue Antigens. 2014 Mar;83(3):147-53. doi: 10.1111/tan.12271. Epub 2014 Jan 10.

PMID:
24405442
36.

HLA frequencies and associations in cystic fibrosis.

Adriaanse MP, Vreugdenhil AC, Groeneweg M, Brüggenwirth HT, Castelijns SJ, van der Ent CK, Voorter CE, Tilanus MG.

Tissue Antigens. 2014 Jan;83(1):27-31. doi: 10.1111/tan.12265.

PMID:
24355005
37.

Effects of transmembrane region variability on cell surface expression and allorecognition of HLA-DP3.

Crivello P, Lauterbach N, Zito L, Sizzano F, Toffalori C, Marcon J, Curci L, Mulder A, Wieten L, Zino E, Voorter CE, Tilanus MG, Fleischhauer K.

Hum Immunol. 2013 Aug;74(8):970-7. doi: 10.1016/j.humimm.2013.04.014. Epub 2013 Apr 23.

PMID:
23619468
38.

Common and well-documented HLA alleles: 2012 update to the CWD catalogue.

Mack SJ, Cano P, Hollenbach JA, He J, Hurley CK, Middleton D, Moraes ME, Pereira SE, Kempenich JH, Reed EF, Setterholm M, Smith AG, Tilanus MG, Torres M, Varney MD, Voorter CE, Fischer GF, Fleischhauer K, Goodridge D, Klitz W, Little AM, Maiers M, Marsh SG, Müller CR, Noreen H, Rozemuller EH, Sanchez-Mazas A, Senitzer D, Trachtenberg E, Fernandez-Vina M.

Tissue Antigens. 2013 Apr;81(4):194-203. doi: 10.1111/tan.12093.

39.

Molecular typing of HLA-E.

Lauterbach N, Voorter CE, Tilanus MG.

Methods Mol Biol. 2012;882:143-58. doi: 10.1007/978-1-61779-842-9_8.

PMID:
22665232
40.

Full-length HLA-DPB1 diversity in multiple alleles of individuals from Caucasian, Black, or Oriental origin.

Lauterbach N, Voorter CE, Stallinga CM, Groeneweg M, Wieten L, Tilanus MG.

Tissue Antigens. 2012 Mar;79(3):165-73. doi: 10.1111/j.1399-0039.2011.01834.x. Epub 2012 Jan 9.

PMID:
22224408
41.

Full-length sequence of a novel null allele HLA-A*23:38N identified in an individual from Guadeloupe.

Joannes MO, Voorter CE, Agis F, Tilanus MG.

Tissue Antigens. 2012 Jan;79(1):71-2. doi: 10.1111/j.1399-0039.2011.01763.x. Epub 2011 Aug 22.

PMID:
21880020
42.

Full-length sequence of a novel HLA-B*15:220 allele identified in an individual from Guadeloupe.

Joannes MO, Voorter CE, Agis F, Tilanus MG.

Tissue Antigens. 2012 Jan;79(1):75-6. doi: 10.1111/j.1399-0039.2011.01762.x. Epub 2011 Aug 22.

PMID:
21859429
43.

Butyrophilin-like 2 in pulmonary sarcoidosis: a factor for susceptibility and progression?

Wijnen PA, Voorter CE, Nelemans PJ, Verschakelen JA, Bekers O, Drent M.

Hum Immunol. 2011 Apr;72(4):342-7. doi: 10.1016/j.humimm.2011.01.011. Epub 2011 Jan 20.

PMID:
21256912
44.

Inactivation of a functional HLA-A gene: a 4-kb deletion turns HLA-A*24 into a pseudogene.

Voorter CE, Lauterbach N, Tilanus MG.

Hum Immunol. 2010 Dec;71(12):1197-202. doi: 10.1016/j.humimm.2010.09.010. Epub 2010 Sep 19.

PMID:
20858522
45.

The role of tumor necrosis factor alpha G-308A polymorphisms in the course of pulmonary sarcoidosis.

Wijnen PA, Nelemans PJ, Verschakelen JA, Bekers O, Voorter CE, Drent M.

Tissue Antigens. 2010 Mar;75(3):262-8. doi: 10.1111/j.1399-0039.2009.01437.x. Epub 2010 Jan 11.

PMID:
20070603
46.

HLA-DP antibodies before and after renal transplantation.

Billen EV, Christiaans MH, Doxiadis II, Voorter CE, van den Berg-Loonen EM.

Tissue Antigens. 2010 Mar;75(3):278-85. doi: 10.1111/j.1399-0039.2009.01428.x. Epub 2010 Jan 11.

PMID:
20070601
47.

M. avium binding to HLA-DR expressed alleles in silico: a model of phenotypic susceptibility to sarcoidosis.

Saltini C, Pallante M, Puxeddu E, Contini S, Voorter CE, Drent M, Amicosante M.

Sarcoidosis Vasc Diffuse Lung Dis. 2008 Dec;25(2):100-16.

PMID:
19382529
48.

Clinical relevance of pretransplant donor-directed antibodies detected by single antigen beads in highly sensitized renal transplant patients.

van den Berg-Loonen EM, Billen EV, Voorter CE, van Heurn LW, Claas FH, van Hooff JP, Christiaans MH.

Transplantation. 2008 Apr 27;85(8):1086-90. doi: 10.1097/TP.0b013e31816b3ed1.

PMID:
18431226
49.

Luminex donor-specific crossmatches.

Billen EV, Voorter CE, Christiaans MH, van den Berg-Loonen EM.

Tissue Antigens. 2008 Jun;71(6):507-13. doi: 10.1111/j.1399-0039.2008.01032.x. Epub 2008 Mar 29.

PMID:
18380779
50.

Reanalysis of sequence-based HLA-A, -B and -Cw typings: how ambiguous is today's SBT typing tomorrow.

Voorter CE, Mulkers E, Liebelt P, Sleyster E, van den Berg-Loonen EM.

Tissue Antigens. 2007 Nov;70(5):383-9. Epub 2007 Sep 16.

PMID:
17868258

Supplemental Content

Loading ...
Support Center